Results 211 to 220 of about 2,242,374 (316)
Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European Countries. [PDF]
Kaló Z +25 more
europepmc +1 more source
Sustainable bioplastics manufacturing from renewable sources
Bioplastics are manufactured by using polymers from different bio‐based sources. These novel materials not only offer biodegradability but also possess various functional properties that make them suitable for diverse applications. Recent developments in the preparation of bioplastics are reported, highlighting the distinct properties of each type of ...
C. Valeria L. Giosafatto +6 more
wiley +1 more source
Drug Stratification Based on Real-World Evidence in Psoriasis: A Narrative Review. [PDF]
Sindrup WG +3 more
europepmc +1 more source
Aged human bmMSCs are seeded in the scaffold. Osteoblastic induction can slightly increase cell's bone‐forming activity to produce bone‐like tissues, shown as the sporadic xylenol orange‐stained spots (the lower left image). Notably, pioglitazone plus EGCG co‐treatment dramatically increases cell's bone‐forming activity and bone‐like tissue production (
Ching‐Yun Chen +6 more
wiley +1 more source
Optimizing Crohn's Disease Management in the Biologic Era-Insights from Real-World Evidence in Japan. [PDF]
Fukuzawa M.
europepmc +1 more source
Enzymatic degradation of biopolymers in amorphous and molten states: mechanisms and applications
This review explains how polymer morphology and thermal state shape enzymatic degradation pathways, comparing amorphous and molten biopolymer structures. By integrating structure–reactivity principles with insights from thermodynamics and enzyme engineering, it highlights mechanisms that enable efficient polymer breakdown.
Anđela Pustak, Aleksandra Maršavelski
wiley +1 more source
Utilization of real-world evidence in regulatory approvals for multiple myeloma therapies. [PDF]
Taylor L, Chen A, Pierre A.
europepmc +1 more source
Chemoresistance in bladder cancer: Macrophage recruitment associated with CXCL1, CXCL5 and CXCL8 expression is characteristic of Gemcitabine/Cisplatin (Gem/Cis) Non‐Responder tumors (right side) while Responder tumors did not show substantial tumor‐stromal crosstalk (left side). All biological icons are attributed to Bioicons: carcinoma, cancerous‐cell‐
Sophie Leypold +11 more
wiley +1 more source
Real-world evidence of finerenone in Type 2 diabetes: addressing confounding and follow-up duration. [PDF]
Chen YH, Fang YW, Tsai MH.
europepmc +1 more source

